Lucid Diagnostics (LUCD) FCF Margin (2021 - 2026)
Lucid Diagnostics (LUCD) posted FCF Margin of 947.38% for Q1 2026, down 12.77% on a QoQ basis from 840.12% in Q4 2025, and up 56928.0% year-over-year from N/an in Q1 2025.
Lucid Diagnostics (LUCD) FCF Margin (2021 - 2026) Analysis & Trends
Lucid Diagnostics' FCF Margin history runs 6 years deep, the most recent figure standing at 947.38% for Q1 2026.
- Quarterly FCF Margin rose 56928.0% year-over-year to 947.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 889.54% (up 16692.0% YoY) and the FY2025 annual result came in at 993.23%, up 2922.0% from the prior year.
- FCF Margin was 947.38% for Q1 2026 at Lucid Diagnostics, down from 840.12% in the prior quarter.
- Across five years, FCF Margin topped out at 824.64% in Q4 2024 and bottomed at 9665.79% in Q3 2022.
- A 5-year average of 2116.09% and a median of 1148.95% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin sank 856079 bps — and 2023, when it jumped 854433 bps.
- Lucid Diagnostics' FCF Margin stood at 3801.79% in 2022, then soared by 75 bps to 959.52% in 2023, then advanced by 14 bps to 824.64% in 2024, then dropped by 2 bps to 840.12% in 2025, then dropped by 13 bps to 947.38% in 2026.
- Business Quant data shows LUCD's FCF Margin at 947.38% in Q1 2026, 840.12% in Q4 2025, and 898.93% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 37.67% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 2.18% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 6.68% |
| 10 | Lucid Diagnostics | 127.91 Mn | 100.03 Mn | -325,000.00 | -947.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -947.38% |
| Dec 31, 2025 | -840.12% |
| Sep 30, 2025 | -898.93% |
| Jun 30, 2025 | -879.08% |
| Mar 31, 2025 | -1,516.67% |
| Dec 31, 2024 | -824.64% |
| Sep 30, 2024 | -868.17% |
| Jun 30, 2024 | -1,176.43% |
| Mar 31, 2024 | -1,259.94% |
| Dec 31, 2023 | -959.52% |
| Sep 30, 2023 | -1,121.46% |
| Jun 30, 2023 | -4,362.89% |
| Mar 31, 2023 | -1,600.22% |
| Dec 31, 2022 | -3,801.79% |
| Sep 30, 2022 | -9,665.79% |
| Mar 31, 2022 | -3,134.39% |
| Dec 31, 2021 | -3,567.00% |
| Sep 30, 2021 | -1,105.00% |